Traditional Chinese medicine preparation for treating coronary heart disease

Abstract

The invention discloses a traditional Chinese medicine preparation for treating the coronary heart disease. The traditional Chinese medicine preparation comprises 20-30 g of slenderstyle acanthopanax bark, 10-20 g of Chinese magnoliavine fruit, 10-20 g of villous amomum fruits, 10-20 g of golden thread, 10-20 g of pseudo-ginseng, 10-20 g of turmeric root-tuber, 10-20 g of szechuan lovage rhizomes, 10-20 g of white sandalwood, 8-12 g of safflower, 8-15 g of heterophylly falsestarwort roots, 8-12 g of prepared membranous milkvetch roots, 8-12 g of dwarf lilyturf tuber, 8-12 g of cassia seeds, 8-12 g of dried toads and 8-12 g of calcined fossil fragments and oysters. The medicines can benefit heart qi, remove blood stasis, eliminate edema when used together and can work together to tonify qi and promote blood circulation and urination, facilitates relief of coronary heart disease symptoms, strengthens functions of visceral organs and has a better curative effect on the coronary heart disease.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine preparation capable of treating coronary heart disease. Background technique [0002] Coronary atherosclerotic heart disease, referred to as coronary heart disease, refers to abnormal lipid metabolism, lipids in the blood are deposited on the original smooth arterial intima, and some atherosclerotic lipid substances accumulate in the arterial intima White plaques, called atherosclerotic lesions. These plaques gradually increase and narrow the arterial lumen, obstructing blood flow, leading to cardiac ischemia and angina pectoris. [0003] Coronary heart disease is a common disease, frequently-occurring disease. It mostly occurs in the age group over 40-50 years old. With the development of society and economy, the improvement of people's living standards and the increase of the proportion of elderly people in the population, the incide...

AI Technical Summary

Problems solved by technology

However, it is also found that about 30% to 50% of patients who receive this therapy will have restenosis in the coronary artery within six months after the operation, which has become a major problem that seriously affects the curative effect of patients with coronary heart disease. At the same time, the stent breaks in the body The problem is also becoming more and more prominent, which may affect the sudden occurrence of myocardial infarction

As for drug treatment, nitric acid, nitrous acid lipids, coronary artery dilators, betaloc, aspirin enteric-coated tablets, etc., although the temporary effect is fast, but the side effects are large, and patients are prone to drug resistance, and the cure rate is low, easy to relapse, palliative